Revelation Biosciences Inc (REVB)
2.37
+0.02
(+0.85%)
USD |
NASDAQ |
May 03, 16:00
2.30
-0.07
(-2.95%)
Pre-Market: 20:00
Revelation Biosciences Price: 2.37 for May 3, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 03, 2024 | 2.38 | 2.430 | 2.30 | 2.37 | 24418.00 |
| May 02, 2024 | 2.23 | 2.49 | 2.161 | 2.35 | 64059.00 |
| May 01, 2024 | 2.08 | 2.225 | 2.08 | 2.15 | 27525.00 |
| Apr 30, 2024 | 2.108 | 2.200 | 2.102 | 2.107 | 9771.00 |
| Apr 29, 2024 | 2.20 | 2.249 | 2.10 | 2.12 | 12728.00 |
| Apr 26, 2024 | 2.13 | 2.31 | 2.12 | 2.18 | 45621.00 |
| Apr 25, 2024 | 2.09 | 2.16 | 2.03 | 2.140 | 9543.00 |
| Apr 24, 2024 | 2.14 | 2.15 | 2.04 | 2.09 | 40461.00 |
| Apr 23, 2024 | 2.03 | 2.19 | 2.03 | 2.07 | 31546.00 |
| Apr 22, 2024 | 2.19 | 2.310 | 2.022 | 2.05 | 22521.00 |
| Apr 19, 2024 | 2.30 | 2.330 | 2.03 | 2.24 | 43274.00 |
| Apr 18, 2024 | 2.20 | 2.38 | 2.125 | 2.24 | 96849.00 |
| Apr 17, 2024 | 1.895 | 2.17 | 1.880 | 2.15 | 126812.0 |
| Apr 16, 2024 | 1.88 | 1.990 | 1.804 | 1.91 | 38419.00 |
| Apr 15, 2024 | 2.14 | 2.23 | 1.780 | 1.825 | 94215.00 |
| Apr 12, 2024 | 2.32 | 2.32 | 2.05 | 2.08 | 57549.00 |
| Apr 11, 2024 | 2.36 | 2.520 | 2.31 | 2.32 | 24615.00 |
| Apr 10, 2024 | 2.45 | 2.49 | 2.28 | 2.31 | 50988.00 |
| Apr 09, 2024 | 2.62 | 2.645 | 2.42 | 2.43 | 42367.00 |
| Apr 08, 2024 | 2.70 | 2.79 | 2.59 | 2.60 | 26150.00 |
| Apr 05, 2024 | 2.76 | 2.84 | 2.58 | 2.67 | 32215.00 |
| Apr 04, 2024 | 2.60 | 2.835 | 2.60 | 2.72 | 45883.00 |
| Apr 03, 2024 | 2.55 | 2.660 | 2.53 | 2.60 | 34847.00 |
| Apr 02, 2024 | 2.71 | 2.71 | 2.53 | 2.59 | 71833.00 |
| Apr 01, 2024 | 2.71 | 2.77 | 2.595 | 2.66 | 33902.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.825
Minimum
Apr 15 2024
11077.50
Maximum
Jan 04 2022
3812.69
Average
487.36
Median
Price Benchmarks
| Cardiff Oncology Inc | 3.52 |
| Ocular Therapeutix Inc | 6.17 |
| Ocugen Inc | 1.33 |
| Cue Biopharma Inc | 2.13 |
| Solid Biosciences Inc | 10.10 |
Price Related Metrics
| PE Ratio | 0.078 |
| Price to Book Value | 0.5822 |
| Earnings Yield | 1.28K% |
| Market Cap | 3.87M |